Navigation Links
Three Pharmacy Benefit Experts to Discuss Post-Discharge Medication Reconciliation Strategies in June 26 Webinar
Date:6/17/2013

Washington, DC (PRWEB) June 17, 2013

When a patient is released from the hospital after a heart attack or other major medical event, he or she may be leaving with one or more new medications that potentially conflict(s) with a pre-existing medication regimen. But who is going to flag any potential drug-to-drug interactions, duplicate therapies, gaps in care or other therapy problems? Three pharmacy benefit experts with considerable experience observing and addressing medication reconciliation issues will review the pros and cons of different strategies in “Post-Discharge Medication Reconciliation Strategies for Health Plans and PBMs,” the upcoming June 26 webinar from Atlantic Information Services, Inc. (AIS).

The more patients bounce from doctor to hospital to other sources of care without an advocate monitoring what medications they’re taking (or not taking), the greater the likelihood of costly hospital readmissions or other unfavorable outcomes, including death. How can health plans and PBMs improve the effectiveness of medication reconciliation? What approaches work best? What outcomes have plan sponsors seen with different programs? And how should medication reconciliation be reimbursed?

In the June 26 webinar, Jan Berger, M.D., M.J., chief medical officer at Silverlink Communications and a longtime advocate of medication therapy management programs, Brian Solow, M.D., F.A.A.F.P., chief medical officer for OptumRx, and Dean T. Parry, R.Ph., director of Pharmacy Clinical Programs at Geisinger Health Plan, will discuss the critical components of medication reconciliation and share strategies to address them. These and other questions will be addressed:

  • How can payers and providers measure whether medication reconciliation is effective and includes not just a routine check of prescribed medications, but also patient education and outcomes measurement?
  • Which model for staffing and coordinating medication reconciliation efforts works best — and for which types of patient groups and plan sponsors?
  • What outcomes have different types of medication reconciliation programs achieved?
  • How should payers reimburse for medication reconciliation — and what role can incentives play in making sure this crucial function is done effectively?
  • How can payers harness the value of the pharmacist to intervene in issues stemming from multiple prescribers?
  • How can integrating medical and pharmacy claims data serve to better manage issues around medication reconciliation?

Visit http://aishealth.com/marketplace/c3p28_062613 for more details and registration information.

About AIS

Atlantic Information Services, Inc. (AIS) is a publishing and information company that has been serving the health care industry for more than 25 years. It develops highly targeted news, data and strategic information for managers in hospitals, health plans, medical group practices, pharmaceutical companies and other health care organizations. AIS products include print and electronic newsletters, websites, looseleafs, books, strategic reports, databases, webinars and conferences. Learn more at http://AISHealth.com.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10836644.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Voices Against Brain Cancer Commends Family For Remaining Positive Despite Three Cancer Diagnoses
2. Accomplished San Diego Dermatologists Nominated for Three ‘Best of San Diego’ 2013 Awards
3. Ascendant Diagnostics™ Welcomes Three to Board of Directors
4. North American Seminars Receives New Jersey Physical Therapy Continuing Education Course Approval for Three New Continuing Education Courses
5. Three Ways To Combat the Fear of Speaking Up in Healthcare from LifeWings
6. Scott Tischler of Tischler Brothers Fitness unveils the three secrets to keeping a workout program going strong
7. Novatus Contract Management Adds Three Key Roles; Positions Itself for Future Growth
8. Scott Tischler of Tischler Brothers Fitness Unveils Three Healthy Eating Tips for a Busy Life Style
9. ContextVision Gains Asian Market Share, Signs Three New Mammography Contracts
10. Addiction Recovery in as Little as Three Days
11. Public Health Accreditation Board Awards National Accreditation to Three Public Health Departments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... Dr. ... New York, has recently begun offering three new minimally invasive procedures to patients ... procedures and reducing downtime, Dr. Rubinstein is excited to bring microneedling, microneedling facials, ...
(Date:6/23/2017)... ... June 23, 2017 , ... Goodcents Deli Fresh Subs today announced the opening ... 4210 SW 21st St. Topeka, Kan. 66604 (near 21st and Gage). It is owned ... owns three other locations in the Topeka and Bonner Springs, Kan. area. , ...
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... ... Breast Cancer Conference from Sept. 18 to 20. , The two-day conference is ... subtype with the goal of improving patients’ lives and eliminating racial breast cancer-related ...
(Date:6/23/2017)... ... June 23, 2017 , ... PureLife Dental is pleased to announce ... for CDA members. As part of the amalgam separator endorsement, all CDA members may ... than $400 off the retail value. This partnership between PureLife and CDA is especially ...
(Date:6/23/2017)... ... June 23, 2017 , ... Ulster University, Magee Campus ... from 9 am to 3 pm to present to graduate students exciting new and ... an original curriculum project led by The Health Improvement Service of the Western Health ...
Breaking Medicine News(10 mins):
(Date:6/5/2017)... The Cincinnati location of ... (NYSE: DPLO), has been awarded a Top Workplaces 2017 ... Results are based on an employee survey administered by WorkplaceDynamics, ... improvement. The survey measures several aspects of workplace culture, including ... ...
(Date:6/3/2017)... June 3, 2017  Eli Lilly and Company ... results from the Phase 3 MONARCH 2 study ... 6 inhibitor, in combination with fulvestrant, significantly improved ... alone in women with hormone-receptor-positive (HR+), human epidermal ... who have relapsed or progressed after endocrine therapy ...
(Date:6/1/2017)... BELL, Pa. , June 1, 2017 ... (PRN) and Veterinarian Recommended Solutions (VRS), and KD Pharma ... investment in Nutriceutical Holdings by KD Pharma Group. KD ... Holdings with the option to acquire the entire company. ... partner in KD. They are committed to growing the ...
Breaking Medicine Technology: